IFNA1 and systemic lupus erythematosus: An important contribution to the understanding of the pathogenesis of SLE was an early observation here in Uppsala that type I interferon (IFN) treatment of patients with malignant diseases could induce autoimmune diseases, including SLE (5, 6).